Product Information
CARVEDILOL 3.125 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0170 per EA under NDC 72888003405. Its NADAC has been published 209 times since Jun 29, 2022.
Strength
3.125 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888003405
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA078165On Market Since
7/29/2021
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 3.125 MG TABLET has been published 209 times since Jun 29, 2022, and over the history we have for it it has declined 11.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0170 per EA |
|---|---|
| All-time high | $0.0200 (Feb 14, 2024) |
| All-time low | $0.0133 (Nov 20, 2024) |
| 52-week high | $0.0174 |
| 52-week low | $0.0163 |
| Median price | $0.0173 |
| Average price | $0.0174 |
| Largest weekly change | -22.2% (Nov 20, 2024) |
| Weeks tracked | 209 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARVEDILOL 3.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 3.125 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0170 per EA (NDC 72888003405), effective Jun 24, 2026.
How has the price of CARVEDILOL 3.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 3.125 MG TABLET has declined 11.1%. It has been tracked across 209 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 3.125 MG TABLET?
Since Jun 29, 2022, the NADAC for CARVEDILOL 3.125 MG TABLET has ranged from a low of $0.0133 (Nov 20, 2024) to a high of $0.0200 (Feb 14, 2024), with a median of $0.0173 per EA.
Are there cheaper alternatives to CARVEDILOL 3.125 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CARVEDILOL 3.125 MG TABLET, but none are currently priced below it.
Who manufactures CARVEDILOL 3.125 MG TABLET?
CARVEDILOL 3.125 MG TABLET (NDC 72888003405) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification